Predictive Indicators of Survival in Patients With Surgically Resected Lung Carcinoid Tumors at a Greek Medical Center.
ki67
pulmonary carcinoids
type of surgery
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
07 Sep 2020
07 Sep 2020
Historique:
entrez:
14
9
2020
pubmed:
15
9
2020
medline:
15
9
2020
Statut:
epublish
Résumé
Introduction Lung carcinoid tumors are neuroendocrine neoplasms, less frequent than other lung tumors. They are subdivided into typical carcinoids (TC) and atypical carcinoids (AC), according to the rate of mitosis and the presence of necrosis. Lung carcinoids are often asymptomatic and only discovered incidentally. They may also present with cough, wheezing, asthma, and chronic obstructive pulmonary disease, chest pain, and hemoptysis depending on the location of the tumor and, less commonly, present with carcinoid syndrome. In our study, we describe the clinical and pathological features of patients with surgically resected lung carcinoids at our institution over a period of 14 years. We also examine if these features, including age, gender, tumor size, type of carcinoid, stage, nodal involvement, and Ki-67 expression are associated with patients' survival. Materials and methods We retrospectively reviewed patients that underwent surgery with a final histologic diagnosis of a pulmonary carcinoid tumor from March 2005 to March 2019. The evaluation included history, physical examination, chest radiographs, computerized tomography of the chest, upper abdomen, and brain, and bone scintiscan. All specimens resected during the surgical procedures were sent for pathological examination, including mediastinal and hilar lymph nodes. The patients' age, gender, tumor size, type of carcinoid, nodal involvement, stage, and Ki-67 expression were recorded and correlated to the patients' survival rates. Results The study included 108 patients - 52 males and 56 females - with a mean age of 51.5 years (range 11-80 years). Atypical carcinoid was the diagnosis in 28 patients (16 males and 12 females) and 80 patients had the diagnosis of typical carcinoid (36 males and 44 females). Tumor size was ≤3.7 cm in 84 patients (68 with TC and 16 with AC) and >3.7 cm in 22 patients (12 with TC and 10 with AC). Sixteen patients had nodal deposits, 12 in N1 nodes and four in N2 nodes. Eighty patients were classified in stage I, 18 patients in stage II, and 10 patients in stage III. None of the patients had distant metastases. The Ki-67 proliferation index was examined in 84 specimens and Ki-67 was <2.5 in 50 patients and ≥2.5 in 34 patients. Of the 108 patients, eight died, all with disease-related death. According to the Cox regression univariate analysis, four factors were correlated to shorter survival: atypical histology, tumor size >3.7 cm, nodal involvement, and advanced stage Conclusions In conclusion, we found that histological type, tumor size, nodal involvement, and stage are associated with survival in patients with surgically resected lung carcinoids without distant metastases. Other parameters, such as age at operation, gender, and Ki-67 index, did not have a role in survival in these patients according to the Cox regression univariate analysis.
Identifiants
pubmed: 32923302
doi: 10.7759/cureus.10300
pmc: PMC7478793
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e10300Informations de copyright
Copyright © 2020, Georgakopoulou et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Hum Pathol. 2000 Oct;31(10):1255-65
pubmed: 11070119
Rev Assoc Med Bras (1992). 2018 Jan;64(1):15-18
pubmed: 29561937
Ann Oncol. 2015 Aug;26(8):1604-20
pubmed: 25646366
Eur J Cardiothorac Surg. 2000 Aug;18(2):156-61
pubmed: 10925223
AJR Am J Roentgenol. 1998 May;170(5):1369-73
pubmed: 9574618
Eur J Cardiothorac Surg. 2014 Mar;45(3):521-6; discussion 526
pubmed: 24092506
Eur J Nucl Med Mol Imaging. 2014 May;41(5):856-64
pubmed: 24435773
Ann Thorac Surg. 2011 Feb;91(2):339-43
pubmed: 21256263
Am J Clin Oncol. 2020 Sep;43(9):607-614
pubmed: 32889829
J Cell Physiol. 2000 Mar;182(3):311-22
pubmed: 10653597
Surg Today. 2020 Mar 19;:
pubmed: 32193632
Lung Cancer. 2020 Jan;139:94-102
pubmed: 31759223
Ochsner J. 2017 Winter;17(4):335-340
pubmed: 29230118
Ann Surg Oncol. 2003 Jul;10(6):697-704
pubmed: 12839856
Interact Cardiovasc Thorac Surg. 2014 Aug;19(2):239-44
pubmed: 24737788
J Thorac Cardiovasc Surg. 2005 Oct;130(4):969-72
pubmed: 16214506
Diagn Interv Radiol. 2019 Jul;25(4):270-279
pubmed: 31295144
J Thorac Oncol. 2015 Sep;10(9):1243-1260
pubmed: 26291008
J Thorac Cardiovasc Surg. 2002 Feb;123(2):303-9
pubmed: 11828290
Cancers (Basel). 2018 Dec 12;10(12):
pubmed: 30545054
Chest. 2007 Jan;131(1):255-60
pubmed: 17218584